$0.697800
0.00010.01%
Last update: 9:09 AM
15 minutes delayed
Comments
Loading...
Biora Therapeutics
BIORNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Biora Therapeutics (NASDAQ:BIOR) Stock, Analyst Ratings, Price Targets, Forecasts
Biora Therapeutics Inc has a consensus price target of $15 based on the ratings of 1 analysts. The high is $15 issued by HC Wainwright & Co. on July 22, 2024. The low is $15 issued by HC Wainwright & Co. on July 22, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on July 22, 2024, May 16, 2024, and January 2, 2024, respectively. With an average price target of $26.67 between HC Wainwright & Co., there's an implied 3764.73% upside for Biora Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Biora Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/22/2024 | Buy Now | 2073.91% | HC Wainwright & Co. | Joseph Pantginis | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2024 | Buy Now | 2073.91% | HC Wainwright & Co. | Joseph Pantginis | → $15 | Reiterates | Buy → Buy | Get Alert |
| 01/02/2024 | Buy Now | 7146.38% | HC Wainwright & Co. | Joseph Pantginis | → $50 | Reiterates | Buy → Buy | Get Alert |
| 10/02/2023 | Buy Now | 7146.38% | HC Wainwright & Co. | Joseph Pantginis | $65 → $50 | Maintains | Buy | Get Alert |
| 08/15/2023 | Buy Now | 9320.29% | HC Wainwright & Co. | Joseph Pantginis | → $65 | Reiterates | Buy → Buy | Get Alert |
| 07/27/2023 | Buy Now | 9320.29% | HC Wainwright & Co. | Joseph Pantginis | → $65 | Reiterates | Buy → Buy | Get Alert |
| 05/16/2023 | Buy Now | 9320.29% | HC Wainwright & Co. | Joseph Pantginis | → $65 | Reiterates | Buy → Buy | Get Alert |
| 01/10/2023 | Buy Now | 9320.29% | HC Wainwright & Co. | Joseph Pantginis | $6 → $65 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Biora Therapeutics (BIOR) stock?
The latest price target for Biora Therapeutics (NASDAQ:BIOR) was reported by HC Wainwright & Co. on July 22, 2024. The analyst firm set a price target for $15.00 expecting BIOR to rise to within 12 months (a possible 2049.61% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Biora Therapeutics (BIOR)?
The latest analyst rating for Biora Therapeutics (NASDAQ:BIOR) was provided by HC Wainwright & Co., and Biora Therapeutics reiterated their buy rating.
When was the last upgrade for Biora Therapeutics (BIOR)?
There is no last upgrade for Biora Therapeutics
When was the last downgrade for Biora Therapeutics (BIOR)?
There is no last downgrade for Biora Therapeutics.
When is the next analyst rating going to be posted or updated for Biora Therapeutics (BIOR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biora Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biora Therapeutics was filed on July 22, 2024 so you should expect the next rating to be made available sometime around July 22, 2025.
Is the Analyst Rating Biora Therapeutics (BIOR) correct?
While ratings are subjective and will change, the latest Biora Therapeutics (BIOR) rating was a reiterated with a price target of $15.00 to $15.00. The current price Biora Therapeutics (BIOR) is trading at is $0.70, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.